Purine nucleotide metabolism regulates expression of the human immune ligand MICA

Michael T. McCarthy, Gerard Moncayo, Thomas K. Hiron, Niels A. Jakobsen, Alessandro Valli, Tomoyoshi Soga, Julie Adam, Christopher A. O'Callaghan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Expression of the cell-surface glycoprotein MHC class I polypeptide- related sequence A (MICA) is induced in dangerous, abnormal, or "stressed" cells, including cancer cells, virus-infected cells, and rapidly proliferating cells. MICA is recognized by the activating immune cell receptor natural killer group 2D (NKG2D), providing a mechanism by which immune cells can identify and potentially eliminate pathological cells. Immune recognition through NKG2D is implicated in cancer, atherosclerosis, transplant rejection, and inflammatory diseases, such as rheumatoid arthritis. Despite the wide range of potential therapeutic applications ofMICAmanipulation, the factors that control MICA expression are unclear. Here we use metabolic interventions and metabolomic analyses to show that the transition from quiescent cellular metabolism to a "Warburg" or biosynthetic metabolic state induces MICA expression. Specifically, we show that glucose transport into the cell and active glycolytic metabolism are necessary to up-regulate MICA expression. Active purine synthesis is necessary to support this effect of glucose, and increases in purine nucleotide levels are sufficient to induce MICA expression. Metabolic induction of MICA expression directly influences NKG2D-dependent cytotoxicity by immune cells. These findings support a model of MICA regulation whereby the purine metabolic activity of individual cells is reflected by cell-surface MICA expression and is the subject of surveillance by NKG2D receptor-expressing immune cells.

Original languageEnglish
Pages (from-to)3913-3924
Number of pages12
JournalJournal of Biological Chemistry
Volume293
Issue number11
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Purine Nucleotides
Metabolism
Cells
Natural Killer Cell Receptors
Ligands
Glucose
Transplants
Membrane Glycoproteins
Cytotoxicity
Viruses
Peptides
purine
Metabolomics
Graft Rejection
Rheumatoid Arthritis
Neoplasms
Atherosclerosis
Up-Regulation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

McCarthy, M. T., Moncayo, G., Hiron, T. K., Jakobsen, N. A., Valli, A., Soga, T., ... O'Callaghan, C. A. (2018). Purine nucleotide metabolism regulates expression of the human immune ligand MICA. Journal of Biological Chemistry, 293(11), 3913-3924. https://doi.org/10.1074/jbc.M117.809459

Purine nucleotide metabolism regulates expression of the human immune ligand MICA. / McCarthy, Michael T.; Moncayo, Gerard; Hiron, Thomas K.; Jakobsen, Niels A.; Valli, Alessandro; Soga, Tomoyoshi; Adam, Julie; O'Callaghan, Christopher A.

In: Journal of Biological Chemistry, Vol. 293, No. 11, 01.01.2018, p. 3913-3924.

Research output: Contribution to journalArticle

McCarthy, MT, Moncayo, G, Hiron, TK, Jakobsen, NA, Valli, A, Soga, T, Adam, J & O'Callaghan, CA 2018, 'Purine nucleotide metabolism regulates expression of the human immune ligand MICA', Journal of Biological Chemistry, vol. 293, no. 11, pp. 3913-3924. https://doi.org/10.1074/jbc.M117.809459
McCarthy, Michael T. ; Moncayo, Gerard ; Hiron, Thomas K. ; Jakobsen, Niels A. ; Valli, Alessandro ; Soga, Tomoyoshi ; Adam, Julie ; O'Callaghan, Christopher A. / Purine nucleotide metabolism regulates expression of the human immune ligand MICA. In: Journal of Biological Chemistry. 2018 ; Vol. 293, No. 11. pp. 3913-3924.
@article{a634fafc430c446ab96cf0d26f43cc09,
title = "Purine nucleotide metabolism regulates expression of the human immune ligand MICA",
abstract = "Expression of the cell-surface glycoprotein MHC class I polypeptide- related sequence A (MICA) is induced in dangerous, abnormal, or {"}stressed{"} cells, including cancer cells, virus-infected cells, and rapidly proliferating cells. MICA is recognized by the activating immune cell receptor natural killer group 2D (NKG2D), providing a mechanism by which immune cells can identify and potentially eliminate pathological cells. Immune recognition through NKG2D is implicated in cancer, atherosclerosis, transplant rejection, and inflammatory diseases, such as rheumatoid arthritis. Despite the wide range of potential therapeutic applications ofMICAmanipulation, the factors that control MICA expression are unclear. Here we use metabolic interventions and metabolomic analyses to show that the transition from quiescent cellular metabolism to a {"}Warburg{"} or biosynthetic metabolic state induces MICA expression. Specifically, we show that glucose transport into the cell and active glycolytic metabolism are necessary to up-regulate MICA expression. Active purine synthesis is necessary to support this effect of glucose, and increases in purine nucleotide levels are sufficient to induce MICA expression. Metabolic induction of MICA expression directly influences NKG2D-dependent cytotoxicity by immune cells. These findings support a model of MICA regulation whereby the purine metabolic activity of individual cells is reflected by cell-surface MICA expression and is the subject of surveillance by NKG2D receptor-expressing immune cells.",
author = "McCarthy, {Michael T.} and Gerard Moncayo and Hiron, {Thomas K.} and Jakobsen, {Niels A.} and Alessandro Valli and Tomoyoshi Soga and Julie Adam and O'Callaghan, {Christopher A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1074/jbc.M117.809459",
language = "English",
volume = "293",
pages = "3913--3924",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - Purine nucleotide metabolism regulates expression of the human immune ligand MICA

AU - McCarthy, Michael T.

AU - Moncayo, Gerard

AU - Hiron, Thomas K.

AU - Jakobsen, Niels A.

AU - Valli, Alessandro

AU - Soga, Tomoyoshi

AU - Adam, Julie

AU - O'Callaghan, Christopher A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Expression of the cell-surface glycoprotein MHC class I polypeptide- related sequence A (MICA) is induced in dangerous, abnormal, or "stressed" cells, including cancer cells, virus-infected cells, and rapidly proliferating cells. MICA is recognized by the activating immune cell receptor natural killer group 2D (NKG2D), providing a mechanism by which immune cells can identify and potentially eliminate pathological cells. Immune recognition through NKG2D is implicated in cancer, atherosclerosis, transplant rejection, and inflammatory diseases, such as rheumatoid arthritis. Despite the wide range of potential therapeutic applications ofMICAmanipulation, the factors that control MICA expression are unclear. Here we use metabolic interventions and metabolomic analyses to show that the transition from quiescent cellular metabolism to a "Warburg" or biosynthetic metabolic state induces MICA expression. Specifically, we show that glucose transport into the cell and active glycolytic metabolism are necessary to up-regulate MICA expression. Active purine synthesis is necessary to support this effect of glucose, and increases in purine nucleotide levels are sufficient to induce MICA expression. Metabolic induction of MICA expression directly influences NKG2D-dependent cytotoxicity by immune cells. These findings support a model of MICA regulation whereby the purine metabolic activity of individual cells is reflected by cell-surface MICA expression and is the subject of surveillance by NKG2D receptor-expressing immune cells.

AB - Expression of the cell-surface glycoprotein MHC class I polypeptide- related sequence A (MICA) is induced in dangerous, abnormal, or "stressed" cells, including cancer cells, virus-infected cells, and rapidly proliferating cells. MICA is recognized by the activating immune cell receptor natural killer group 2D (NKG2D), providing a mechanism by which immune cells can identify and potentially eliminate pathological cells. Immune recognition through NKG2D is implicated in cancer, atherosclerosis, transplant rejection, and inflammatory diseases, such as rheumatoid arthritis. Despite the wide range of potential therapeutic applications ofMICAmanipulation, the factors that control MICA expression are unclear. Here we use metabolic interventions and metabolomic analyses to show that the transition from quiescent cellular metabolism to a "Warburg" or biosynthetic metabolic state induces MICA expression. Specifically, we show that glucose transport into the cell and active glycolytic metabolism are necessary to up-regulate MICA expression. Active purine synthesis is necessary to support this effect of glucose, and increases in purine nucleotide levels are sufficient to induce MICA expression. Metabolic induction of MICA expression directly influences NKG2D-dependent cytotoxicity by immune cells. These findings support a model of MICA regulation whereby the purine metabolic activity of individual cells is reflected by cell-surface MICA expression and is the subject of surveillance by NKG2D receptor-expressing immune cells.

UR - http://www.scopus.com/inward/record.url?scp=85044120250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044120250&partnerID=8YFLogxK

U2 - 10.1074/jbc.M117.809459

DO - 10.1074/jbc.M117.809459

M3 - Article

C2 - 29279329

AN - SCOPUS:85044120250

VL - 293

SP - 3913

EP - 3924

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 11

ER -